Where I see patients (3)
Selected research
Clinical trials
International Rare Brain Tumor Registry
The primary outcome measure will be time from diagnosis to an event, defined as the occurrence of progression or recurrence of the disease, occurrence of a second malignant neoplasm, or death from any cause. Each cohort will be an...
Recruiting
More about this studyContact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program
